Clinical Trials Browser

Phase 2 × Margins of Excision × Sunitinib × Clear all

NCT01784978 2017-10-02

SUNRISES

Phase 2 Terminated

Margins of Excision, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms